Literature DB >> 3133386

Comparative immunochemistry of lipopolysaccharides from typable and polyagglutinable Pseudomonas aeruginosa strains isolated from patients with cystic fibrosis.

A Fomsgaard1, R S Conrad, C Galanos, G H Shand, N Høiby.   

Abstract

Lipopolysaccharide (LPS) was extracted and purified from three Pseudomonas aeruginosa strains isolated from the infected lungs of patients with cystic fibrosis. Two of the strains could be typed by O-specific antibody (O:3 and O:9), and the third was polyagglutinable (O:3/9). The separated LPS was characterized by chemical and serological methods. The main neutral sugar constituents (glucose, rhamnose, and heptose) were found in various proportions in the three strains, whereas the amounts of glucosamine, galactosamine, ketodeoxyoctonate, and phosphate were more constant. Ester-bound C12, C16, 3-OH-C10, and 2-OH-C12, together with amide-bound 3-OH-C12, fatty acids were present in equimolar proportions in all three strains. Considerable amounts of LPS were liberated in the culture supernatant of the O:3 bacteria but not in those from the other two strains. This free LPS was shown to be immunologically identical to the cell-bound LPS and the extracted LPS. By sodium dodecyl sulfate-polyacrylamide gel electrophoresis, O:3 and O:9 LPS showed a ladder pattern characteristic of smooth LPS, while O:3/9 LPS appeared rough. Rabbit antisera used for O-typing were found by enzyme-linked immunosorbent assay to contain anti-LPS antibodies that reacted strongly with homologous LPS, moderately with O:3/9 LPS, and slightly with heterologous LPS. Immunoblotting showed that common antigenic determinants in the core-lipid A part were involved in the observed cross-reaction. The polyagglutinability of P. aeruginosa may be explained by the antibodies to these common determinants that arose from the partial absence of O polysaccharides.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3133386      PMCID: PMC266467          DOI: 10.1128/jcm.26.5.821-826.1988

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  23 in total

1.  The specificity of agglutination reactions of Pseudomonas aeruginosa with O antisera.

Authors:  T L Pitt; Y J Erdman
Journal:  J Med Microbiol       Date:  1978-02       Impact factor: 2.472

2.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

3.  A new method for the extraction of R lipopolysaccharides.

Authors:  C Galanos; O Lüderitz; O Westphal
Journal:  Eur J Biochem       Date:  1969-06

4.  A new and improved microassay to determine 2-keto-3-deoxyoctonate in lipopolysaccharide of Gram-negative bacteria.

Authors:  Y D Karkhanis; J Y Zeltner; J J Jackson; D J Carlo
Journal:  Anal Biochem       Date:  1978-04       Impact factor: 3.365

5.  Immunization, isolation of immunoglobulins, estimation of antibody titre.

Authors:  N Harboe; A Ingild
Journal:  Scand J Immunol Suppl       Date:  1973

6.  The relationship between the O-antigenic lipopolysaccharides and serological specificity in strains of Pseudomonas aeruginosa of different O-serotypes.

Authors:  I R Chester; P M Meadow; T L Pitt
Journal:  J Gen Microbiol       Date:  1973-10

7.  Polyagglutinability due to loss of O-antigenic determinants in Pseudomonas aeruginosa strains isolated from cystic fibrosis patients.

Authors:  B Ojeniyi; L Baek; N Høiby
Journal:  Acta Pathol Microbiol Immunol Scand B       Date:  1985-02

8.  Cellular and free lipopolysaccharides of some species of Neisseria.

Authors:  K G Johnson; M B Perry; I J McDonald; R R Russel
Journal:  Can J Microbiol       Date:  1975-12       Impact factor: 2.419

9.  Changes in serotype caused by cell to cell contact between different Pseudomonas aeruginosa strains from cystic fibrosis patients.

Authors:  B Ojeniyi; V T Rosdahl; N Høiby
Journal:  Acta Pathol Microbiol Immunol Scand B       Date:  1987-02

Review 10.  Composition and structure of lipopolysaccharides from Pseudomonas aeruginosa.

Authors:  S G Wilkinson
Journal:  Rev Infect Dis       Date:  1983 Nov-Dec
View more
  26 in total

1.  Use of pulsed-field gel electrophoresis as an epidemiologic tool during an outbreak of Pseudomonas aeruginosa lung infections in an intensive care unit.

Authors:  D Talon; G Capellier; A Boillot; Y Michel-Briand
Journal:  Intensive Care Med       Date:  1995-12       Impact factor: 17.440

2.  Growth-dependent alterations in production of serotype-specific and common antigen lipopolysaccharides in Pseudomonas aeruginosa PAO1.

Authors:  E J McGroarty; M Rivera
Journal:  Infect Immun       Date:  1990-04       Impact factor: 3.441

3.  Interactions of surfactant protein D with bacterial lipopolysaccharides. Surfactant protein D is an Escherichia coli-binding protein in bronchoalveolar lavage.

Authors:  S F Kuan; K Rust; E Crouch
Journal:  J Clin Invest       Date:  1992-07       Impact factor: 14.808

4.  Nonopsonic antibodies in cystic fibrosis. Pseudomonas aeruginosa lipopolysaccharide-specific immunoglobulin G antibodies from infected patient sera inhibit neutrophil oxidative responses.

Authors:  I Eichler; L Joris; Y P Hsu; J Van Wye; R Bram; R Moss
Journal:  J Clin Invest       Date:  1989-12       Impact factor: 14.808

5.  Pseudomonas aeruginosa lipopolysaccharide: evidence that the O side chains and common antigens are on the same molecule.

Authors:  K Hatano; J B Goldberg; G B Pier
Journal:  J Bacteriol       Date:  1993-08       Impact factor: 3.490

6.  Specific IgG2 antibodies to Pseudomonas aeruginosa lipid A and lipopolysaccharide are early markers of chronic infection in patients with cystic fibrosis.

Authors:  G Kronborg; T Pressler; A Fomsgaard; C Koch; N Høiby
Journal:  Infection       Date:  1993 Sep-Oct       Impact factor: 3.553

Review 7.  Microbiology of airway disease in patients with cystic fibrosis.

Authors:  P H Gilligan
Journal:  Clin Microbiol Rev       Date:  1991-01       Impact factor: 26.132

8.  Antibody responses to lipid A, core, and O sugars of the Pseudomonas aeruginosa lipopolysaccharide in chronically infected cystic fibrosis patients.

Authors:  G Kronborg; A Fomsgaard; C Galanos; M A Freudenberg; N Høiby
Journal:  J Clin Microbiol       Date:  1992-07       Impact factor: 5.948

9.  Longitudinal study of antibody response to lipopolysaccharides during chronic Pseudomonas aeruginosa lung infection in cystic fibrosis.

Authors:  A Fomsgaard; N Høiby; G H Shand; R S Conrad; C Galanos
Journal:  Infect Immun       Date:  1988-09       Impact factor: 3.441

10.  Enhancement of lipopolysaccharide-induced tumor necrosis factor secretion by hyperimmune serum from chronic infected patients.

Authors:  G Kronborg; A Fomsgaard; N Høiby
Journal:  Med Microbiol Immunol       Date:  1993-12       Impact factor: 3.402

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.